Petrus Bekker, SVP of Medical & Clinical at ChemoCentryx, Inc. (CCXI), sold 13,889 shares at $14.01 ($193K) on 2013-03-15, disclosed to the SEC on 2013-03-19.
Scheduled sale ($193k) by SVP of Medical & Clinical under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.00 | 485 | $7K | 3.5% |
| 2 | $14.01 | 941 | $13K | 6.8% |
| 3 | $14.04 | 1,633 | $23K | 11.9% |
| 4 | $14.05 | 1,992 | $28K | 14.5% |
| 5 | $14.08 | 2,103 | $30K | 15.3% |
| 6 | $14.11 | 1,735 |
| $24K |
| 12.7% |
| 7 | $13.61 | 5,000 | $68K | 35.3% |
| Total | $13.90 avg | 13,889 | $193K | 100% |
| Filing → |
| CCXI | SELL | 2017-06-30 | $760K | — | Filing → |
| CCXI | SELL | 2016-12-20 | $134K | — | Filing → |
| CCXI | SELL | 2016-12-07 | $255K | — | Filing → |